|
am there
lots of her2 agents, mTor inhibitors, HSP 90 inhibitors in trials with really hopeful results.
Her2 bc felt to have been changed from worse prognosis than her2- to better prognosis for many (those who respond and don't develop resistance) New agents for those who don't respond or develop resistance and usually to be ADDED to herceptin or lapatinib.
Herceptin/lapatinib combo felt to be promising as well.
More later!
Lani
|